One Ascent Financial Services LLC Neurocrine Biosciences Inc Transaction History

One Ascent Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $185,890 - $213,607	-2,157 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$87.57 - $119.4 $171,111 - $233,307	-1,954 Reduced 47.53%	2,157 $210,000
Q4 2020 Jan 13, 2021	BUY	$86.91 - $108.33 $124,715 - $155,453	1,435 Added 53.62%	4,111 $394,000
Q3 2020 Nov 02, 2020	BUY	$96.16 - $135.15 $37,694 - $52,978	392 Added 17.16%	2,676 $257,000
Q2 2020 Jul 21, 2020	BUY	$85.09 - $130.36 $194,345 - $297,742	2,284 New	2,284 $279,000

627

94.3M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on One Ascent Financial Services LLC with notifications on news.